CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2008; 18(04): 290-294
DOI: 10.4103/0971-3026.43840
COMMENTARY

PET/CT: Current status in India

Venkatesh Rangarajan
Bioimaging Unit, Tata Memorial Center, Parel, Mumbai, 400012, India
,
Nilendu C Purandare
Bioimaging Unit, Tata Memorial Center, Parel, Mumbai, 400012, India
,
Anshu R Sharma
Bioimaging Unit, Tata Memorial Center, Parel, Mumbai, 400012, India
,
Sneha Shah
Bioimaging Unit, Tata Memorial Center, Parel, Mumbai, 400012, India
› Author Affiliations
Financial support and sponsorship Nil.

Abstract

PET/CT is a new modality with integration of PET and CT systems. In India, since December 2004 there has been a steady increase in the number of imaging systems. From stand-alone PET/CT systems with on-site cyclotrons, mostly in the government sector, the modality has matured to such an extent that, today, the majority of the PET/CT scanners and cyclotrons are in the private setup; also, scanners situated in different locations (and even different cities) share the isotope produced from one cyclotron. This shows how much this field has developed and reflects the confidence of the end users. The current status of PET/CT in India is indeed healthy and heartening and the future certainly looks promising.



Publication History

Article published online:
31 July 2021

© 2008. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Endo K, Oriuchi N, Higuchi T, Iida Y, Hanaoka H, Miyakubo M, et al . PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients. Int J Clin Oncol 2006;11:286-96.
  • 2 Townsend DW. Dual-modality imaging: Combining anatomy and function. J Nucl Med 2008;49:938-55.
  • 3 Blokland JA, Trindev P, Stokkel MP, Pauwels EK. Positron emission tomography: A technical introduction for clinicians. Eur J Radiol 2002;44:70-5.
  • 4 McQuade P, Rowland DJ, Lewis JS, Welch MJ. Positron-emitting isotopes produced on biomedical cyclotrons. Curr Med Chem 2005;12:807-18.
  • 5 Availabel from: http://www.aerb.gov.in/.
  • 6 Gollub MJ, Hong R, Sarasohn DM, Akhurst T. Limitations of CT During PET/CT. J Nucl Med 2007;48:1583-91.
  • 7 Wong TZ, Paulson EK, Nelson RC, Patz EF Jr, Coleman RE. Practical approach to diagnostic CT combined with PET. AJR Am J Roentgenol 2007;188:622-9.
  • 8 Elstrom RL, Leonard JP, Coleman M, Brown RK. Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma. Ann Oncol 2008; [Epub ahead of print].
  • 9 Jadvar H, Connolly LP, Fahey FH, Shulkin BL. PET and PET/CT in pediatric oncology. Semin Nucl Med 2007;37:316-31.
  • 10 Brunetti J, Caggiano A, Rosenbluth B, Vialotti C. Technical aspects of positron emission tomography/computed tomography fusion planning. Semin Nucl Med 2008;38:129-36.